These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27259396)

  • 1. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.
    Khabou H; Desrosiers M; Winckler C; Fouquet S; Auregan G; Bemelmans AP; Sahel JA; Dalkara D
    Biotechnol Bioeng; 2016 Dec; 113(12):2712-2724. PubMed ID: 27259396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.
    Bennett A; Keravala A; Makal V; Kurian J; Belbellaa B; Aeran R; Tseng YS; Sousa D; Spear J; Gasmi M; Agbandje-McKenna M
    J Struct Biol; 2020 Feb; 209(2):107433. PubMed ID: 31859208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2.
    Cui M; Su Q; Yip M; McGowan J; Punzo C; Gao G; Tai PWL
    Gene Ther; 2024 Sep; 31(9-10):489-498. PubMed ID: 39134629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
    Michelfelder S; Varadi K; Raupp C; Hunger A; Körbelin J; Pahrmann C; Schrepfer S; Müller OJ; Kleinschmidt JA; Trepel M
    PLoS One; 2011; 6(8):e23101. PubMed ID: 21850255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes.
    Gurtsieva D; Minskaia E; Zhuravleva S; Subcheva E; Sakhibgaraeva E; Brovin A; Tumaev A; Karabelsky A
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38276507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
    Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE
    J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
    Shen X; Storm T; Kay MA
    Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina.
    Hickey DG; Edwards TL; Barnard AR; Singh MS; de Silva SR; McClements ME; Flannery JG; Hankins MW; MacLaren RE
    Gene Ther; 2017 Dec; 24(12):787-800. PubMed ID: 28872643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.
    Yang GS; Schmidt M; Yan Z; Lindbloom JD; Harding TC; Donahue BA; Engelhardt JF; Kotin R; Davidson BL
    J Virol; 2002 Aug; 76(15):7651-60. PubMed ID: 12097579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain.
    Sullivan JA; Stanek LM; Lukason MJ; Bu J; Osmond SR; Barry EA; O'Riordan CR; Shihabuddin LS; Cheng SH; Scaria A
    Gene Ther; 2018 Jun; 25(3):205-219. PubMed ID: 29785047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer retinal transduction by AAV2-7m8 following intravitreal injection in a sheep model of CNGA3 achromatopsia.
    Ross M; Obolensky A; Averbukh E; Desrosiers M; Ezra-Elia R; Honig H; Yamin E; Rosov A; Dvir H; Gootwine E; Banin E; Dalkara D; Ofri R
    Gene Ther; 2022 Nov; 29(10-11):624-635. PubMed ID: 34853444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
    Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
    Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion.
    Kellish PC; Marsic D; Crosson SM; Choudhury S; Scalabrino ML; Strang CE; Hill J; McCullough KT; Peterson JJ; Fajardo D; Gupte S; Makal V; Kondratov O; Kondratova L; Iyer S; Witherspoon CD; Gamlin PD; Zolotukhin S; Boye SL; Boye SE
    Mol Ther; 2023 Dec; 31(12):3441-3456. PubMed ID: 37814449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered AAV13 variants with enhanced transduction and confined spread.
    Luo NS; Cai YX; Han ZP; Sui XK; Yuan WJ; Zhang ZL; Guo HD; Wang J; Lin KZ; Xu FQ
    Zool Res; 2024 Jul; 45(4):781-790. PubMed ID: 38894521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.
    Mowat FM; Gornik KR; Dinculescu A; Boye SL; Hauswirth WW; Petersen-Jones SM; Bartoe JT
    Gene Ther; 2014 Jan; 21(1):96-105. PubMed ID: 24225638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Modification of the AAV5 Capsid with Lysine Residues Results in a Lung-Tropic Liver-Detargeted Gene Transfer Vector.
    Stiles KM; Frenk EZ; Kaminsky SM; Crystal RG
    Hum Gene Ther; 2022 Feb; 33(3-4):148-154. PubMed ID: 35018834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.